Clinician/patient interaction: Communicating the benefits and risks of oral contraceptives

Contraception

Volumn 59, Issue 1 SUPPL., 1999, Pages 39S-42S

  Davis, Ann ^a   Wysocki, Susan ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b National Association of Nurse Practitioners in Women's Health   (United States)

Author keywords

Clinican patient interaction; Counseling; Oral contraceptives

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; BREAST CANCER; CARDIOVASCULAR DISEASE; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH HAZARD; HUMAN; MENOPAUSE; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT EDUCATION; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

EID: 0032966105     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00137-1     Document Type: Article

References (22)

1. Peipert J.F., Gutmann J. Oral contraceptive risk assessment a survey of 247 educated women . Obstet Gynecol. 82:1993;112-117.
2. Tessler S.L., Peipert J.F. Perceptions of contraceptive effectiveness and health effects of oral contraception. Women's Health Issues. 7:1997;400-406.
3. Killick S.R. Patient education and understanding a critical review . Adv Contracep. 8:(Suppl 1):1992;57-65.
4. Endometrial cancer and combined oral contraceptives. Int J Epidemiol. 17:1988;263-269.
5. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med. 316:1987;650-655.
6. Breast cancer and hormonal contraceptives collaborative breast cancer reanalysis of individual data on 53 297 women with and 100 239 women without breast cancer from 54 epidemiological studies . Lancet. 347:1996;1713-1727.
7. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet. 346:1995;1582-1588.
8. Petitti D.B., Sidney S., Bernstein A., et al. Stroke in users of low-dose oral contraceptives. N Engl J Med. 335:1996;8-15.
9. Acute myocardial infarction and combined oral contraceptives results of an international multicentre case-control study . Lancet. 349:1997;1202-1209.
10. Kaunitz A.M. Oral contraceptive health benefits perception versus reality . Contraception. 59:1999;29S-33S.
11. Westoff C.L. Breast cancer risk perception versus reality . Contraception. 59:1999;25S-28S.
12. Asbell B. The Pill A Biography of the Drug That Changed the World . 1995;19-20 Random House, New York.
13. Jick H., Jick S.S., Gurewich V., et al. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 346:1995;1589-1593.
14. Farmer R.D.T., Preston T.D. The risk of venous thromboembolism associated with low oestrogen oral contraceptives. J Obstet Gynecol. 15:1996;195-200.
15. Mishell D.R. Jr. Cardiovascular risks perception versus reality . Contraception. 59:1999;21S-24S.
16. Women's attitudes toward oral contraceptives and other forms of birth control. 1994;Princeton, New Jersey.
17. Hatcher R.A., Guillebaud J. The pill combined oral contraceptives . Hatcher R.A., Trussell J., Stewart F., et al. Contraceptive Technology. 17th ed. 1998;405-466 Ardent Media, Inc, New York.
18. Neinstein L.S. Adolescent Health Care. A Practical Guide, 2nd ed. 1991;39-44 Urban & Schwarzenberg, Baltimore.
19. Mishell D.R. Jr. Contraception. N Engl J Med. 320:1989;777-787.
20. Redmond G.P., Olson W.H., Lippman J.S., et al. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris a randomized, placebo-controlled trial . Obstet Gynecol. 89:1997;615-622.
21. Lucky A.W., Henderson T.A., Olson W.H., et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 37:1997;746-754.
22. Ory HW. The noncontraceptive health benefits from oral contraceptive use. Fam Plann Perspect 1982;14:182-4.